The SM Journey: Sharing
Explore insights and strategies for managing the disease long-term.
-
-
Study finds avapritinib offers long-term symptom improvement in indolent SM
-
New research highlights the high symptom burden of indolent SM
-
Drug-induced anaphylaxis can be the first sign of SM
-
Needle-free epinephrine may transform emergency treatment for anaphylaxis
-
Researchers examine how SM affects mortality risk
-
Is it age, or SM? Getting older with a rare disease
